US EditionBack-to-School Rush Spurs Demand for Epinephrine Auto-Injectors Amid Shortage | News Channel 3-12
Back-to-school demand increases epinephrine auto-injector fills by nearly 33% from July to August, worsening existing shortages and supply-chain strain, officials and GoodRx report.
- Amid the back-to-school rush, GoodRx reports summer demand spikes for epinephrine auto-injectors as of June 25, 2025, may worsen shortages.
- Amid restocking for the new term, parents and schools typically drive a nearly 33% increase in fills from July to August, coinciding with peak prescriptions.
- Supply-Chain strain emerges as Mylan has back orders for EpiPen and EpiPen Jr with no estimated release dates.
- During shortages, pharmacies may not fill all or part of prescriptions, so patients are advised to discuss alternatives with prescribers.
- On Aug. 9, 2024, the FDA approved neffy, the first needle-free spray for anaphylaxis, with out-of-pocket costs ranging from nearly $300 to over $850 for a pack of two injectors.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
Back-to-school rush spurs demand for epinephrine auto-injectors amid shortage | News Channel 3-12
Erin Deleon // Shutterstock Back-to-school rush spurs demand for epinephrine auto-injectors amid shortage As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer months. And this season’s demand may intensify existing shortages of this lifesaving medication. Epinephrine prescriptions typically peak in Aug…
Coverage Details
Total News Sources11
Leaning Left1Leaning Right0Center10Last UpdatedBias Distribution91% Center
Bias Distribution
- 91% of the sources are Center
91% Center
C 91%
Factuality
To view factuality data please Upgrade to Premium
